Anzahl der Einträge: 17.
Walter, I.,
Schulz, U.,
Vogelhuber, M.,
Wiedmann, K.,
Endlicher, E.,
Klebl, F.,
Andreesen, R.,
Herr, W.,
Ghibelli, L.,
Hackl, C.,
Wiest, R. und
Reichle, A.
(2017)
Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial.
Medical Oncology 34 (12).
Volltext nicht vorhanden.
Bentz, S.,
Cee, A.,
Endlicher, E.,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference,
make_name_string expected hash reference und
make_name_string expected hash reference 
(2013)
Hypoxia Induces the Expression of Transketolase-Like 1 in Human Colorectal Cancer.
Digestion 88, S. 182-192.
Fensterer, H.,
Schade-Brittinger, C.,
Müller, H.-H.,
Tebbe, S.,
Fass, J.,
Lindig, U.,
Settmacher, U.,
Schmidt, W.E.,
Märten, A.,
Ebert, M.P.,
Kornmann, M.,
Hofheinz, R.,
Endlicher, E.,
Brendel, C.,
Barth, P.J.,
Bartsch, D.K.,
Michl, P. und
Gress, T.M. 
(2013)
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP).
Annals of Oncology 24 (10), S. 2576-2581.
Volltext nicht vorhanden.
Schlinqensiepen, K.,
Oettle, H.,
Seufferlein, T.,
Luger, T.,
Schmid, R.M.,
von Wiehert, G.,
Endlicher, E.,
Garbe, C.,
Kaehler, K.C. und
Enk, A.
(2011)
1233 POSTER Phase l/lI Study With Trabedersen (AP 12009) Monotherapy for the Treatment of Patients With Advanced Pancreatic Cancer, Malignant Melanoma or Colorectal Carcinoma.
European Journal of Cancer 47, S154.
Volltext nicht vorhanden.
Fensterer, H.,
Schade-Brittinger, C.,
Mueller, H.,
Schupfner, B.,
Fass, J.,
Lindig, U.,
Settmacher, U.,
Ebert, M. P.,
Kornmann, M.,
Hofheinz, R.,
Endlicher, E.,
Brendel, C.,
Barth, P. J.,
Bartsch, D. K. und
Gress, T. M.
(2011)
Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.
Journal of Clinical Oncology 29 (15_sup), S. 4039.
Volltext nicht vorhanden.
Oettle, H.,
Hilbig, A.,
Seufferlein, T.,
Tsianakas, A.,
Luger, T.,
Schmid, R. M.,
von Wichert, G.,
Endlicher, E.,
Garbe, C.,
Kaehler, K. K.,
Hauschild, A.,
Enk, A.,
Kiessling, P.,
Schmaus, S.,
Heinrichs, H. und
Schlingensiepen, K.
(2011)
Phase I/II study with trabedersen (AP 12009) monotherapy for the treatment of patients with advanced pancreatic cancer, malignant melanoma, and colorectal carcinoma.
Journal of Clinical Oncology 29 (15_sup), S. 2513.
Volltext nicht vorhanden.
Laffranchi, B.,
De Jonge, M. J.,
Bajetta, E.,
Hendlisz, A.,
Giuliani, R.,
Barone, C.,
Endlicher, E.,
Jannuzzo, M. G.,
Spinelli, R. und
Santoro, A.
(2010)
Phase II study of danusertib (D) in advanced/metastatic colorectal and pancreatic cancers (CRC, PC).
Journal of Clinical Oncology 28 (15_sup), e13558-e13558.
Volltext nicht vorhanden.
Endlicher, E.,
Troppmann, M.,
Kullmann, A.,
Gölder, S.,
Herold, T.,
Herfarth, H.,
Grossmann, J.,
Schlottmann, K. und
Kullmann, F.
(2008)
Irinotecan plus Gemcitabine and 5-Fluorouracil in Advanced Pancreatic Cancer: A Phase II Study.
Oncology 72 (5-6), S. 279-284.
Volltext nicht vorhanden.
Reichle, A.,
Walpinski, S.,
Vogelhuber, M.,
Wiedmann, K.,
Berand, A.,
Endlicher, E.,
Klebl, F.,
Schölmerich, J.,
Andreesen, R. und
Wiest, R.
(2008)
Targeted anti-inflammatory and angiostatic therapy in pretreated patients with advanced hepatocellular carcinoma.
Journal of Clinical Oncology 26 (15_sup), S. 15560.
Volltext nicht vorhanden.
Kullmann, F.,
Hollerbach, S.,
Fuchs, M.,
Messmann, H.,
Dollinger, M.M.,
Trojan, J.,
Harder, J.,
Gaebele, E.,
Hinke, A. und
Endlicher, E.
(2007)
3533 POSTER Cetuximab plus Gemcitabine/Oxaliplatin (GEMOXCET) in 1st line metastatic pancreatic cancer–amulticenter phase II study.
European Journal of Cancer Supplements 5 (4), S. 269.
Volltext nicht vorhanden.
Ott, C.,
Ratiu, N.,
Endlicher, E.,
Rath, H. C.,
Gelbmann, C. M.,
Schölmerich, J. und
Kullmann, F.
(2007)
Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes.
Surgical Endoscopy 21 (6), S. 889-896.
Volltext nicht vorhanden.
Endlicher, E.,
Rümmele, P.,
Beer, S.,
Knüchel, R.,
Rath, H.,
Schlottmann, K.,
Grossmann, J.,
Woenckhaus, U.,
Schölmerich, J. und
Messmann, H.
(2005)
Barrett’s Esophagus: a Discrepancy between Macroscopic and Histological Diagnosis.
Endoscopy 37 (11), S. 1131-1135.
Volltext nicht vorhanden.
Brunner, H.,
Hausmann, F.,
Krieg, R. C.,
Endlicher, E.,
Schölmerich, J.,
Knuechel, R. und
Messmann, H.
(2001)
The Effects of 5-Aminolevulinic Acid Esters on Protoporphyrin IX Production in Human Adenocarcinoma Cell Lines¶.
Photochemistry and Photobiology 74 (5), S. 721.
Volltext nicht vorhanden.
Diese Liste wurde erzeugt am Mon Dec 8 00:20:14 2025 CET.